Document:

Agreement, dated July 2, 2012

 Exhibit 10.1 
 AGREEMENT 
 THIS AGREEMENT (“Agreement”), dated as of
July 2, 2012, is entered into by and between BMC Software, Inc., a Delaware corporation (the “Company”), and Elliott Associates, L.P., a Delaware limited partnership, and Elliott International, L.P., a Cayman Islands limited
partnership (together, the “Stockholders”). 
 WITNESSETH: 

WHEREAS, the Stockholders are currently the beneficial owners of approximately 10,419,000 shares (the “Shares”) of the
common stock, par value $0.01 per share, of the Company (“Common Stock”), which represents approximately 6.55% of the issued and outstanding shares of Common Stock; 

WHEREAS, the Stockholders have given notice to the Company of their intention to (i) nominate Thomas Hogan, Carl James Schaper, John
Dillon and Andreas Mattes (the “Contested Election”) and (ii) bring before the Company’s stockholders the proposal described in the Elliott Proxy Statement (as defined below), in each case at the 2012 annual meeting of the
Company’s stockholders scheduled to be held on July 25, 2012 (the “2012 Meeting”); 
 WHEREAS, the
Stockholders are currently engaged in a solicitation of proxies from the Company’s stockholders with respect to the matters described in the immediately preceding recital; 

WHEREAS, the Stockholders have made a number of filings with the Securities and Exchange Commission (the “SEC”) in
connection with such solicitation and the Contested Election, including the Stockholders’ definitive proxy statement, filed with the SEC on June 14, 2012 (the “Elliott Proxy Statement”) 

WHEREAS the Company has accepted the Stockholders’ nominations for each of Carl James Schaper and John Dillon (together, the
“Nominees”) as candidates for election to the Board; and 
 WHEREAS, the Company and the Stockholders desire to
resolve the Contested Election and all matters related thereto and, in furtherance thereof, undertake the actions and agreements contained herein. 
 NOW, THEREFORE, in consideration of the foregoing and the mutual promises, representations, warranties, covenants and agreements of the parties contained herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged by each of the parties hereto, the parties hereto, intending to be legally bound hereby, agree as follows: 

 ARTICLE 1 
 BOARD OF DIRECTORS 
 1.1 Director Nominees 

Having considered the request of the Stockholders that the Nominees be nominated for election to the Company’s board of directors
(the “Board”) at the 2012 Meeting, the Corporate Governance & Nominating Committee of the Board (the “Nominating Committee”) has reviewed the nominations and questionnaires and has recommended that the
Board nominate the Nominees for election as directors of the Company at the 2012 Meeting on the terms set out in this Agreement. For the avoidance of doubt, in addition to the Nominees, the Company intends to also nominate the ten incumbent
directors for re-election at the 2012 Meeting. Based upon such recommendation, concurrent with the execution and delivery of this Agreement, the Board (i) has increased the size of the Board by two directors (to a total of 12 directors),
effective as of the 2012 Meeting and (ii) has determined and agreed to nominate the Nominees for election as directors of the Company at the 2012 Meeting, and to prepare, file with the Securities and Exchange Commission and disseminate to the
Company’s stockholders supplemental proxy soliciting materials describing the terms of this Agreement. If a Nominee is elected by the Company’s stockholders to serve as a director on the Board at the 2012 Meeting, such Nominee shall serve
until the annual meeting of stockholders of the Company in 2013 (the “2013 Meeting”), or until his earlier death, resignation, disqualification or removal. The Stockholders acknowledge and agree that the Company shall be under no
obligation to nominate any Nominee or any other designee of the Stockholders for election to the Board at the 2013 Meeting. 

The size of the Board may be increased to more than 12 directors during the Covered Period (as defined below) only (i) after the
2012 Meeting and (ii) upon a unanimous vote of the Board. 
 The Company (A) shall use commercially reasonable efforts
to convene and hold the 2012 Meeting on July 25, 2012 or as soon thereafter as is reasonably practicable and (B) shall use the same solicitation efforts on behalf of the Nominees as for all other nominees. 

The Company agrees that if any Nominee is unable to serve as a director during the Covered Period as a result of death or disability, the
Stockholders shall be entitled to nominate a substitute person to fill the resulting vacancy, subject to the approvals of the Nominating Committee and of the Board, in each case after consideration of the substitute person in good faith and
exercising its fiduciary duties. 
 1.2 Committee Participation 
 Immediately following the 2012 Meeting, the Board shall hold a meeting of the Board at which it shall appoint (a) Carl James Schaper to the Compensation Committee and (b) John Dillon to the
M&A Committee. 
 ARTICLE 2 
 COVENANTS 

  
 2 

 2.1 Covenants of the Stockholders 

 

	 	(a)	The Stockholders hereby irrevocably withdraw their notice of intention to nominate directors and present a proposal at the 2012 Annual Meeting, as described in the
Elliott Proxy Statement, subject to the Company’s compliance with the first paragraph of Section 1.1 of this Agreement. 

  

	 	(b)	The Stockholders shall (i) immediately cease, and shall cause their respective affiliates to cease, any and all solicitation efforts in connection with the
Contested Election and (ii) promptly notify the staff of the SEC in writing that they are terminating the Contested Election and the solicitation pursuant to the Elliott Proxy Statement. 

 

	 	(c)	The Stockholders shall not vote, deliver or otherwise use any proxies that may have been received to date pursuant to the Contested Election. 

 

	 	(d)	Each of the Stockholders agrees with the Company that, at the 2012 Meeting, it shall vote all of the shares of Common Stock beneficially owned by it:

  

	 	(i)	for each of the Company’s nominees for election to the Board; and 

  

	 	(ii)	in favor of each of the other matters being voted on at the 2012 Meeting as described in the Company’s Proxy Statement on Schedule 14A, filed with the SEC on
June 6, 2012. 

  

	 	(e)	Each of the Stockholders agrees with the Company that, during the period commencing on the date hereof and ending on the date when this Agreement terminates in
accordance with Section 4.1 (the “Covered Period”), it shall not, and shall cause each of its affiliates or any of their respective directors, officers, partners, members and agents (acting in such capacity) (collectively,
“Representatives”) not to, in any manner, directly or indirectly, alone or in concert with others: 

  

	 	(i)	effect or seek to effect, whether alone or in concert with others, any tender or exchange offer, merger, consolidation, acquisition, scheme, arrangement, business
combination, recapitalization, reorganization, sale or acquisition of material assets, liquidation, dissolution or other extraordinary transaction involving the Company or any of its subsidiaries or joint ventures or any of their respective
securities (each, an “Extraordinary Transaction”); provided, however, that this clause (i) shall not preclude the tender by a Stockholder of any securities of the Company into any tender or exchange offer or vote by a
Stockholder of any voting securities of the Company with respect to any Extraordinary Transaction; 

  

	 	(ii)	 form, join, encourage, influence, advise or in any way participate in a “partnership, limited partnership, syndicate or other group” (within
the 

  
 3 

	 	
meaning of Section 13(d)(3) of the United States Securities Exchange Act of 1934 (the “Exchange Act”)) with respect to any securities of the Company (other than any
“group” solely among the Stockholders and their affiliates (the “Stockholder Affiliates”); provided that the Stockholder Affiliates shall not include either competitors of the Company or companies in the computer software
industry) or otherwise in any manner agree, attempt, seek or propose to deposit any securities of the Company or any securities convertible or exchangeable into or exercisable for any such securities in any voting trust or similar arrangement, or
subject any securities of the Company to any arrangement or agreement with respect to the voting thereof, except as expressly set forth in this Agreement; 

  

	 	(iii)	make, engage in, or in any way participate in, directly or indirectly, any “solicitation” of proxies (as such terms are used in the proxy rules of the SEC but
without regard to the exclusion set forth in Rule 14a-1(l)(2)(iv)) or consents to vote, or seek to advise, encourage or influence any person with respect to the voting of any securities of the Company for the election of individuals to the Board or
to approve stockholder proposals, or become a “participant” in any contested “solicitation” for the election of directors with respect to the Company (as such terms are defined or used under the Exchange Act), other than a
“solicitation” or acting as a “participant” in support of all of the nominees of the Board at any stockholder meeting; 

  

	 	(iv)	make or be the proponent of any stockholder proposal (pursuant to Rule 14a-8 under the Exchange Act or otherwise); 

 

	 	(v)	(A) call or seek to call any meeting of stockholders, including by written consent, (B) seek representation on the Board, except as set forth herein, (C) seek
the removal of any member of the Board, (D) solicit consents from stockholders, (E) conduct a referendum of stockholders or (F) make a request for any stockholder list or other similar Company records; 

 

	 	(vi)	sell, offer or agree to sell, all or substantially all, directly or indirectly, through swap or hedging transactions or otherwise, voting rights decoupled from the
underlying Common Stock held by the Stockholders to any Third Party (as defined below); 

  

	 	(vii)	 take any action, alone or in concert with others, in support of or make any proposal or request that constitutes: (A) advising, controlling,
changing or influencing the Board or management of the Company, including any plans or proposals to change the number or term of directors or (except as provided in Section 1.1) to fill any vacancies on the Board, (B) any material change
in the capitalization or dividend policy of the Company, (C) any other material change in the Company’s management, business or corporate structure, (D) seeking to have the Company waive, or make amendments or modifications to, the
Company’s Certificate of Incorporation or Bylaws, or other actions which may impede the 

  
 4 

	 	
acquisition of control of the Company by any person, (E) causing a class of securities of the Company to be delisted from, or to cease to be authorized to be quoted on, any securities
exchange or (F) causing a class of equity securities of the Company to become eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; 

 

	 	(viii)	enter into any discussions, negotiations, agreements or understandings with any Third Party with respect to the foregoing, or advise, assist, intentionally encourage or
seek to persuade any Third Party to take any action with respect to any of the foregoing, or otherwise take or cause any action inconsistent with any of the foregoing; or 

 

	 	(ix)	request, directly or indirectly, any amendment or waiver of the foregoing matters. 

For purposes of this Agreement, the terms “affiliate” and “associate” shall have the respective meanings set forth in
Rule 12b-2 promulgated by the SEC under the Exchange Act, and the term “Third Party” shall mean any person or entity that is not a party to this Agreement or an affiliate thereof, a member of the Board, a director or officer of the
Company, or legal counsel to any party to this Agreement. 
 The foregoing provisions of this Section 2.1(e) shall not be
deemed to prohibit the Stockholders and their Representatives from (i) communicating privately with the Company’s directors, officers or advisors so long as such communications are not intended to, and would not reasonably be expected to,
require any public disclosure of such communications, (ii) publicly commenting on an Extraordinary Transaction after the date hereof, or (iii) negotiating with a Third Party which has entered into a publicly-announced binding written
agreement with the Company providing for a transaction to acquire the Company, to be an equity participant or lender in such acquisition proposal. 
  

	 	(f)	The Stockholders shall, and shall cause their applicable affiliates to promptly file an amendment to their Schedule 13D reporting entry into this Agreement, amending
applicable items to conform to their obligations hereunder and appending or incorporating by reference this Agreement as an exhibit thereto. The Stockholders shall provide the Company with a copy of such amendment to their Schedule 13D within a
reasonable period (and, in any event, at least one business day) in advance of filing such amendment with the SEC in order to provide the Company with a reasonable opportunity to review and comment on such materials. The Stockholders shall, in good
faith, take into consideration the comments received from the Company on such amendment and shall take reasonable efforts to incorporate such comments into the applicable materials. 

 

	 	(g)	 In accordance with the terms of the confidentiality agreement (the “Confidentiality Agreement”), dated June 4, 2012, entered into by and
between the Stockholders and the Company, the Stockholders shall promptly certify to the destruction of the 

  
 5 

 
originals and all copies of the Produced Documents (as defined in the Confidentiality Agreement), subject to the proviso in Section 6 thereof. 

2.2 Covenants of the Company 
  

	 	(a)	The Company shall promptly file a Form 8-K reporting entry into this Agreement and appending or incorporating by reference this Agreement as an exhibit thereto.

  

	 	(b)	The Company shall provide the Stockholders with copies of (i) the Form 8-K referenced in clause (a) above and (ii) the supplemental proxy soliciting
materials describing the terms of this Agreement referenced in Section 1.1 or other solicitation materials that contain statements related to the Stockholders or the Nominees, in each case, within a reasonable period (and, in any event, at
least one business day) in advance of filing such materials with the SEC in order to provide the Stockholders with a reasonable opportunity to review and comment on such materials. The Company shall, in good faith, take into consideration the
comments received from the Stockholders on such materials and shall take reasonable efforts to incorporate such comments into the applicable materials. 

 ARTICLE 3 
 REPRESENTATIONS AND WARRANTIES 

3.1 Representations of the Stockholders 
 The Stockholders represent and warrant as follows: 
  

	 	(a)	The Stockholders have the power and authority to execute, deliver and carry out the terms and provisions of this Agreement and to consummate the transactions
contemplated hereby. 

  

	 	(b)	This Agreement has been duly and validly authorized, executed and delivered by the Stockholders, constitutes a valid and binding obligation and agreement of the
Stockholders and is enforceable against the Stockholders in accordance with its terms. 

  

	 	(c)	The Stockholders, together with their affiliates, beneficially own, directly or indirectly, an aggregate of approximately 10,419,000 shares of Common Stock and such
shares of Common Stock constitute all of the Common Stock beneficially owned by the Stockholders and their affiliates. 

  

	 	(d)	To the knowledge of the Stockholders, each of the Nominees (A) is “independent” under the NASDAQ Stock Market, Inc. listing standards and Rule 10A-3 of
the Exchange Act and (B) is not an “interested person”, as defined in the Investment Company Act of 1940, as amended, of the Stockholders. 

 3.2 Representations of the Company 
 The Company represents and warrants as
follows: 

  
 6 

	 	(a)	The Company has the power and authority to execute, deliver and carry out the terms and provisions of this Agreement and to consummate the transactions contemplated
hereby. 

  

	 	(b)	This Agreement has been duly and validly authorized, executed and delivered by the Company, constitutes a valid and binding obligation and agreement of the Company and
is enforceable against the Company in accordance with its terms. 

 ARTICLE 4 

TERMINATION 
 4.1
Termination 
 This Agreement shall remain in full force and effect until the earliest of: 

 

	 	(a)	The Company’s material breach of its obligations under Section 1.1 or 1.2 of this Agreement, provided that (if such breach is curable) the Shareholders have
provided written notice to the Company of such breach and such breach has not been cured within a five day period; 

  

	 	(b)	the date that is 30 days prior to the expiration of the earlier of the Company’s advance notice period for the nomination of directors or the Company’s
advance notice period for the submission of proposals at the 2013 Meeting, which dates shall only be deemed to refer the notice periods as established by the Company’s Amended and Restated Bylaws and shall not, in any event, be deemed to refer
to the date for submission of stockholder proposals as established by Rule 14a-8 of the Exchange Act; 

  

	 	(c)	the date that each of the Nominees has resigned or been removed from any one or more committee(s) of the Board to which such Nominee has been appointed, other than as a
result of their inability to serve; and 

  

	 	(d)	such other date established by mutual written agreement of the Company and the Stockholders. 

 4.2 Effect of Termination 
 Article 5 shall survive the termination of this
Agreement. No termination pursuant to Section 4.1 shall relieve any party hereto from liability for any breach of this Agreement prior to such termination. 
 ARTICLE 5 
 GENERAL 

5.1 Notices 
 All
notices, requests, claims, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given to a party if delivered in person or 

  
 7 

 
sent by overnight delivery (providing proof of delivery) to the party at the following addresses (or at such other address for a party as shall be specified by like notice) on the date of
delivery, or if by facsimile, upon confirmation of receipt: 
  

			
	 If to the Company:
	  	 BMC Software, Inc.
 2101
CityWest Boulevard
 Houston, TX 77042-2827
 Attention: Patrick K. Tagtow
 Telephone: 713-918-3301

Facsimile: 713-918-8000

		
	 with a copy (which shall not constitute notice) to
	  	 Wachtell, Lipton, Rosen & Katz
 51 West 52nd Street
 New York, NY 10019
 Attention: David C. Karp
 Telephone: 212-403-1327

Facsimile: 212-403-2327

		
	 If to the Stockholders and any of their Representatives
	  	 c/o Elliott Management Corporation
 40 West 57th Street
 New York, NY 10019
 Attention: Jesse Cohn
 Telephone: 212-478-2870

Facsimile: 212-478-2871

		
	 with a copy (which shall not constitute notice) to
	  	 Schulte Roth & Zabel LLP

919 Third Avenue
 New York, NY 10022

Attention: Marc Weingarten

                  David Rosewater

Telephone: 212-756-2000
 Facsimile:
212-593-5955

 5.2 No Third-Party Beneficiaries 
 Nothing in this Agreement, whether express or implied, is intended to or shall confer any rights, benefits or remedies under or by reason of this Agreement on any persons other than the parties hereto,
nor is anything in this Agreement intended to relieve or discharge the obligation or liability of any third persons to any party. 
 5.3
Communications 

  
 8 

 The parties agree that the press release attached as Exhibit A will be issued upon
execution of this Agreement. 
 During the Covered Period, each party hereto shall refrain from making, causing to be made, or
allowing any of its Representatives from making, any public statement or announcement that disparages the business or any current or former officers, employees, or directors of the other. The foregoing shall not prevent (i) any public statement
or announcement with respect to an Extraordinary Transaction that is publicly announced by the Company after the date of this Agreement, (ii) the making of any factual statement as required by applicable legal process, subpoena, or legal
requirement or as part of a response to a request for information from any governmental authority with jurisdiction over the party from whom information is sought. 
 5.4 Governing Law 
 This Agreement shall be governed and construed in
accordance with the laws of the State of Delaware, without regard to the conflict of law principles thereof. The parties and their respective Representatives: (a) irrevocably and unconditionally consent and submit to the jurisdiction of the
state and federal courts located in the State of Delaware for purposes of any action, suit or proceeding arising out of or relating to this Agreement; (b) agree that service of any process, summons, notice or document by U.S. registered mail to
the address set forth in Section 5.1 of this Agreement shall be effective service of process for any action, suit or proceeding brought against them; (c) irrevocably and unconditionally waive any objection to the laying of venue of any
action, suit or proceeding arising out of or relating to this Agreement in any state or federal court located in the State of Delaware; and (d) irrevocably and unconditionally waive the right to plead or claim, and irrevocably and
unconditionally agree not to plead or claim, that any action, suit or proceeding arising out of or relating to this Agreement that is brought in any state or federal court located in the State of Delaware has been brought in an inconvenient forum.

 5.5 Assignment 
 This Agreement shall be binding upon and inure to the benefit of and be enforceable only by the parties hereto. No party to this Agreement may assign its rights or delegate its obligations under this
Agreement, whether by operation of law or otherwise. 
 5.6 Amendments; Waivers 

This Agreement may only be amended pursuant to a written agreement executed by all the parties, and no waiver of compliance with any
provision or condition of this Agreement and no consent provided for in this Agreement shall be effective unless evidenced by a written instrument executed by the party against whom such waiver or consent is to be effective. No failure or delay by a
party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power or privilege
hereunder. 
 5.7 Entire Agreement 

  
 9 

 This Agreement constitutes the entire agreement of all the parties and supersedes any and
all prior and contemporaneous agreements, memoranda, arrangements and understandings, both written and oral, between the parties, or any of them, with respect to the subject matter hereof. No representation, warranty, promise, inducement or
statement of intention has been made by any party which is not contained in this Agreement and no party shall be bound by, or be liable for, any alleged representation, promise, inducement or statement of intention not contained herein. The parties
expressly disclaim reliance on any information, statements, representations or warranties regarding the subject matter of this Agreement other than the terms of this Agreement. 
 5.8 Counterparts 
 This Agreement may be executed in any number of
counterparts (including by facsimile transmission), each of which shall be deemed to be an original, but all of which together shall constitute one binding agreement on the parties, notwithstanding that not all parties are signatories to the same
counterpart. 
 5.9 Expenses 
 All attorneys’ fees, costs and expenses incurred in connection with this Agreement and all matters related hereto will be paid by the party incurring such fees, costs or expenses. 

5.10 Captions 
 The
captions contained in this Agreement are for convenience only and shall not affect the construction or interpretation of any provisions of this Agreement. 
 5.11 Specific Performance 
 The parties agree that irreparable damage would
occur in the event any of the provisions of this Agreement were not performed in accordance with the terms hereof and that such damage would not be adequately compensable in damages. It is accordingly agreed that the parties are entitled to seek an
injunction or specific performance of the terms hereof in addition to any other remedies at law or in equity, and a party will not take any action, directly or indirectly, in opposition to another party seeking relief on the grounds that any other
remedy or relief is available at law or in equity, and the parties further agree to waive any requirement for the security or posting of any bond in connection with such remedy or relief. 

[Remainder of Page Intentionally Left Blank; Signature Page Follows] 

  
 10 

 IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date
first above written. 
  

			
	BMC SOFTWARE, INC.
		
	By:	 	/s/ Patrick K. Tagtow
	Name:	 	Patrick K. Tagtow
	Title:	 	Senior Vice President, General Counsel & Secretary

  

			
	ELLIOTT ASSOCIATES, L.P.
		
	By:	 	Elliott Capital Advisors, L.P., as General Partner
	By:	 	Braxton Associates, Inc., as General Partner
		
	By:	 	/s/ Elliot Greenberg
	Name:	 	Elliot Greenberg
	Title:	 	Vice President

  

			
	ELLIOTT INTERNATIONAL, L.P.
		
	By:	 	 Elliott International Capital Advisors Inc.,
 as Attorney-in-Fact

		
	By:	 	/s/ Elliot Greenberg
	Name:	 	Elliot Greenberg
	Title:	 	Vice President

 [Signature Page to the Settlement Agreement between BMC Software, Inc. and Elliott] 

 EXHIBIT A 
 PRESS RELEASE 
 BMC Software, Inc. issued the following press release on July 3, 2012

  
 

 
 BMC Software Announces Agreement with Elliott Management 

Jim Schaper and John Dillon to be Added to BMC Slate 
 HOUSTON, July 03, 2012 – BMC Software, Inc. (NASDAQ: BMC) (the “Company” or “BMC”), the recognized leader in Business Service Management, has reached an agreement with
Elliott Associates, L.P. and Elliott International, L.P., funds affiliated with Elliott Management Corporation (collectively, “Elliott”) in connection with the Company’s 2012 Annual Meeting of Stockholders scheduled for July 25,
2012 (the “2012 Annual Meeting”). 
 Under the terms of the agreement, the BMC Board of Directors has increased the size of the Board
to 12 directors, effective as of the 2012 Annual Meeting. After review by BMC’s Corporate Governance & Nominating Committee, John Dillon and Jim Schaper have been added to the slate of existing BMC director candidates recommended by
the BMC Board for election at the 2012 Annual Meeting. 
 In addition, Elliott has withdrawn its notice of nomination of all of its director
candidates to the BMC Board and has agreed to vote its shares in favor of each of the BMC Board’s nominees at the 2012 Annual Meeting. Furthermore, Elliott has agreed to abide by certain “standstill” restrictions. 

Upon the election of the revised slate, 11 of BMC’s 12 directors will be independent. Also under the terms of the agreement, upon election,
Mr. Dillon will serve as a member of the Mergers and Acquisitions Committee and Mr. Schaper will serve as a member of the Compensation Committee. 
 Bob Beauchamp, BMC’s Chairman and Chief Executive Officer, said, “BMC’s Board and senior management team remain highly committed to enhancing value for all BMC stockholders. We believe this
settlement with Elliott is an excellent outcome that will serve all BMC stockholders well, and we will welcome Mr. Schaper and Mr. Dillon to our Board. We look forward to working with them to build an even stronger future for BMC.”

 Jesse Cohn, Elliott Portfolio Manager, said, “We are very pleased to have worked constructively with BMC’s management and Board to
reach this favorable outcome. We believe BMC is a great company with a strong product portfolio and a committed customer base – and one that possesses significant value which can be realized through a variety of pathways. Jim and John will add
exceptional expertise as they work collaboratively with the existing Board and senior management team to create value for all BMC stockholders.” 
 The 2012 Annual Meeting will be held on Wednesday, July 25, 2012, at 8:00 a.m. Central Time, in the Gateway IV room at the Grand Hyatt DFW in Dallas, Texas. The record date for determining
eligibility to vote at the 2012 Annual Meeting is June 4, 2012. 
 The settlement agreement between BMC and Elliott will be included as an
exhibit to the Company’s Current Report on Form 8-K to be filed with the Securities and Exchange Commission. 

 Jim Schaper is a veteran of the technology industry, with more than 30 years experience working in leading
enterprise software companies. Mr. Schaper is currently Chairman of Infor Global Solutions, a top Enterprise Software provider with operations in more than 40 countries around the world. Mr. Schaper founded Infor Global Solutions in 2002
and has helped oversee its expansion to becoming the third largest provider of enterprise applications and solutions, with over 85,000 customers, 13,000 employees and $2.8 billion in annual revenues. Previously, Mr. Schaper held executive
positions at Primis Corporation, Medaphis Corporation and Dun & Bradstreet Software. He is also an Operating Partner at Golden Gate Capital, and serves on the Board of a variety of software and technology companies. 

John Dillon has extensive experience as a CEO and Director for a diverse group of leading publicly traded and private cloud computing, SaaS and PaaS
companies. Mr. Dillon is currently the CEO of Engine Yard, the leading cloud platform for automating and developing Ruby on Rails and PHP applications. Previously, Mr. Dillon was the CEO of Navis, a private software company, was the CEO of
Salesforce.com and was CEO and Director of Hyperion Solutions. He spent five years in Sales Management at Oracle, and before beginning his civilian career, was a nuclear submarine officer in the U.S. Navy. Mr. Dillon serves on the Board of
Directors of a private software company and a regional community bank. 
 Morgan Stanley & Co. LLC is serving as financial advisor and
Wachtell, Lipton, Rosen & Katz is serving as legal counsel to the Company. 
 Business Runs on IT. IT Runs on BMC Software.

 Business runs better when IT runs at its best. More than 20,000 IT organizations – from the Global 100 to the smallest businesses
– in over 120 countries rely on BMC Software (NASDAQ: BMC) to manage their business services and applications across distributed, mainframe, virtual and cloud environments. With the leading Business Service Management platform, Cloud
Management, and the industry’s broadest choice of IT management solutions, BMC helps customers cut costs, reduce risk and achieve business objectives. For the four fiscal quarters ended March 31, 2012, BMC revenue was approximately $2.2
billion. For more information, please visit www.bmc.com. 
 ### 

BMC, BMC Software, and the BMC Software logo are the exclusive properties of BMC Software Inc., are registered with the U.S. Patent
and Trademark Office, and may be registered or pending registration in other countries. All other BMC trademarks, service marks, and logos may be registered or pending registration in the U.S. or in other countries. All other trademarks or
registered trademarks are the property of their respective owners. © Copyright 2012 BMC Software Inc.

 FORWARD LOOKING STATEMENTS 

This Press Release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended, which are identified by the use of the words “believe,” “expect,” “anticipate,” “estimate,” “will,” “contemplate,”
“would” and similar expressions that contemplate future events. Such forward-looking statements are based on management’s reasonable current assumptions and expectations. Numerous important factors, risks and uncertainties, including,
but not limited to, those contained in our documents and reports filed with the Securities and Exchange Commission (the “SEC”), affect our operating results and could cause our actual results, levels of activity, performance or achievement
to differ materially from the results expressed or implied by these or any other forward-looking statements made by us or on our behalf. There can be no assurance that future results will meet expectations. You

 
should carefully review the cautionary statements described in the documents and reports we file from time to time with the SEC, specifically our Annual Reports on Form 10-K, our Quarterly
Reports on Form 10-Q and our Current Reports on Form 8-K. Information contained on our website is not part of this Press Release. 
 Readers are
cautioned not to place undue reliance on any forward-looking statements contained in this Press Release, which reflect management’s opinions only as of the date hereof. Except as required by law, we undertake no obligation to revise or publicly
release the results of any revision to any forward-looking statements. 
 CERTAIN INFORMATION REGARDING PARTICIPANTS 

BMC Software, Inc. (“BMC”), its directors and certain of its executive officers are deemed participants in the solicitation of proxies
from BMC stockholders in connection with the matters to be considered at BMC’s 2012 Annual Meeting. In connection with the solicitation of proxies, BMC has filed a definitive proxy statement and other relevant documents concerning the proposals
to be presented at BMC’s 2012 Annual Meeting with the SEC. In connection with the 2012 Annual Meeting, BMC has mailed the definitive proxy statement to stockholders. INVESTORS AND STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ BMC’S
DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ACCOMPANYING WHITE PROXY CARD AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT
INFORMATION. Detailed information regarding the identity of participants, and their direct or indirect interests, by security holdings or otherwise, are set forth in the definitive proxy statement BMC filed with the SEC on June 5, 2012.
Additional information can also be found in BMC’s Annual Report on Form 10-K for the year ended March 31, 2012, filed with the SEC on May 10, 2012. To the extent holdings of BMC securities have changed since the amounts printed in the
definitive proxy statement for the 2012 Annual Meeting, such changes have been or will be reflected on Statements of Changes in Beneficial Ownership of Securities on Form 4 filed with the SEC. Stockholders will be able to obtain any proxy statement,
any amendments or supplements to the proxy statement and other documents filed by BMC with the SEC for no charge at the SEC’s website at www.sec.gov. Copies will also be available at no charge at the Investors section of our corporate website
at http:// investors.bmc.com. 
 BMC Software Contacts 
 Investors: 
 Derrick Vializ 
 BMC Software, Inc. 
 713-918-1805 
 derrick_vializ@bmc.com 
 or 
 Thomas Germinario / Jordan Kovler / Richard Grubaugh 
 D.F. King & Co., Inc. 

212-269-5550 

 Media: 
 Joele Frank / Andy Brimmer / Jennifer Friedman 
 Joele Frank, Wilkinson Brimmer Katcher 

212-355-4449 
 Elliott Management Media
Contacts 
 Peter Truell 

Elliott Management 
 212-478-2080 

or 
 Tom Johnson 

Abernathy MacGregor 
 212-371-5999Amendment to the Stock and Asset Purchase Agreement

 Exhibit 10.1 
 AMENDMENT TO THE 
 SHARE AND ASSET PURCHASE AGREEMENT 

This Amendment (this “Amendment”), dated June 30, 2012, to the Share and Asset Purchase Agreement, dated
April 20, 2012 (the “Agreement”) is made by and among CareFusion 303, Inc., a Delaware corporation (“CFN 303”), CareFusion 2200, Inc., a Delaware corporation (“CFN 2200”, and together with CFN
303, the “Sellers”) and Natus Medical Incorporated, a Delaware corporation (the “Purchaser”). 

The Sellers and Purchaser wish to amend the Agreement (including certain Schedules and Exhibits thereto) as further set forth herein.

 NOW, THEREFORE, intending to be legally bound and in consideration of the premises, and of the representations, warranties,
covenants and agreements contained herein and in the Agreement, the parties agree as follows: 
 Section 1. Definitions;
Spanish Customer Transfer Agreement. 
 (a) Unless otherwise defined herein, capitalized terms defined in the Agreement shall
have the same meaning when used in this Amendment. 
 (b) A new Exhibit D will be annexed to the Agreement, in the form of
Exhibit I hereto, and Section 1.1 of the Agreement is hereby amended by adding the following defined term: 

“Spanish Customer Transfer Agreement” means the agreement between CareFusion Iberia 308, S.L. and Natus Europe GmbH
which provides for the treatment of certain tenders relating to the Business in Spain from Closing, in the form attached hereto as Exhibit D. 
 (c) The defined term “Ancillary Agreements,” in Section 1.1 of the Agreement, is hereby amended to include the Spanish Customer Transfer Agreement. 

(d) Section 9.1(b) of the Agreement is hereby amended by (i) deleting the reference to “and” immediately preceding
clause (v) therein and inserting a comma in lieu thereof, and adding a new clause (vi) to read as follows: 

“(vi) any Taxes resulting from the transactions described in Articles 3 and 4 of the Spanish Customer Transfer Agreement.”

 Section 2. Designated Affiliates. 
 (a) The Designated Affiliates, nominated by Purchaser, are as set forth on Exhibit II hereto. 
 (b) Section 8.2 of the Agreement is hereby amended by (i) deleting the reference to “and” immediately preceding clause (c) therein and inserting a comma in lieu thereof, and
(ii) adding, at the end of clause (c) thereof, a new clause (d) to read as follows: 

 “, all increases in reasonable out-of-pocket costs in respect of Taxes (such as any
Transfer Tax or VAT, including as a result of any resulting failure to be treated as a TOGC), to the Sellers or any Selling Affiliate arising as a result of any Designated Affiliate nominated by Purchaser not being formed or organized in the
jurisdiction in which the applicable Purchased Assets or Transferred Employees are located immediately prior to Closing. For the avoidance of doubt, nothing in this Section 8.2 is intended to override or change Section 9.8 of the
Agreement.” 
 (c) Section 9.8(d) of the Agreement is hereby amended and restated in its entirety as follows:

 “The Purchaser agrees to indemnify and hold harmless the Sellers and each Selling Affiliate against any Liability for
VAT, fines, surcharges, interest or penalties arising to the Sellers or a Selling Affiliate as a result of the failure of the transfer of the Purchased Assets to qualify, in whole or in part, as a TOGC, but only to the extent that such failure
arises solely as a consequence of (i) the Purchaser breaching the covenants in Section 9.8(b) or the representations and warranties set out in Section 9.8(c); (ii) Purchaser’s decision to terminate any Employees; and/or
(iii) Purchaser’s decision to use third parties to distribute products with respect to the Business in Spain, Italy and/or the Netherlands.” 
 (d) For the avoidance of doubt, the parties acknowledge and agree that, provided that the Sellers have complied in all respects with Section 2.11 of the Agreement, with respect to any assignment or
transfer of any Contract or Governmental Authorization to a Designated Affiliate, if such Contract or Governmental Authorization is terminated by the Sellers or their Affiliates, Purchaser shall indemnify and hold harmless the Sellers and their
Affiliates for all reasonable out-of-pocket costs incurred with respect to any such termination. 
 Section 3. Transfer
Documents. Section 2.2 of the Agreement is hereby amended by adding the following sentence at the end of such section: 

“Notwithstanding anything to the contrary contained in any Business Transfer Agreement entered into in connection with the Closing
(a) any conflict between this Agreement and any Business Transfer Agreement is to be governed by and shall be resolved in favor of the applicable provision of this Agreement (including, by way of example, the formulation of Purchased Assets,
Assumed Liabilities, Excluded Assets and Excluded Liabilities, purchase price adjustments, indemnification obligations of Purchaser and the Sellers, and allocation of Liabilities to Purchaser and the Sellers arising out of or related to Transferred
Employees or Taxes), and (b) neither the Sellers nor the Purchaser will (and each party will cause its Affiliates not to) use or rely on any Business Transfer Agreement as a means of avoiding the terms and provisions of, or as a defense to any
of the Sellers’ or Purchaser’s obligations under, this Agreement.” 
 Section 4. Transfer of
Inventory. 
 (a) Section 2.1(b)(i) of the Agreement is hereby amended and restated in its entirety as follows:

  
 - 2 -

 “(i) All Inventory of the Asset Selling Affiliates as of the Closing Date
(collectively, the “Purchased Inventory”); provided, however, that the Purchaser may not acquire possession of the Purchased Inventory located at the Houten, Netherlands and Florence, Italy facilities until after Closing;”

 (b) Section 2.4(a) of the Agreement is hereby amended and restated in its entirety as follows: 

“(i) all other Liabilities of the Asset Selling Affiliates to the extent relating to the Purchased Assets (including those reflected
in Closing Net Working Capital). For the avoidance of doubt, the Purchaser (and its Designated Affiliates) bear all Liabilities and risk of loss with respect to the Purchased Inventory located at the Houten, Netherlands and Florence, Italy
facilities as of and from the Closing;” 
 (c) The Purchaser has requested that certain Inventory be delivered by the
Sellers (or applicable Selling Affiliates or Acquired Companies) to the Purchaser’s (or its Affiliate’s) facility in Munich, Germany prior to Closing (the “Pre-Delivered Inventory”). The parties hereby acknowledge and
agree as follows: 
 (i) while legal title in the Pre-Delivered Inventory will not transfer (directly or
indirectly) to Purchaser or the applicable Designated Affiliates until Closing, the Purchaser (and its Designated Affiliates) shall bear all Liabilities and risk of loss with respect to the Pre-Delivered Inventory as of and from the date of delivery
to Purchaser’s (or its Affiliate’s) facility in Munich, Germany; and 
 (ii) if Closing does not occur,
Purchaser shall return such Pre-Delivered Inventory to Sellers (or the applicable Selling Affiliates or Acquired Companies), at Purchaser’s cost and, upon completion of such delivery, the terms of sub-paragraph (i) above shall no longer
apply to such returned Pre-Delivered Inventory. 
 Section 5. Closing Adjustment. 

(a) Part (a) of the definition of “Closing Net Working Capital” is hereby amended and restated in its entirety as
follows: 
 “means (a) the sum of all Accounts Receivable, Intercompany Receivables (excluding Non-Trade Intercompany
Receivables), Inventory, Additional Gort Inventory, VAT recoverable of the Acquired Companies, and prepaid expenses of the Acquired Companies and to the extent incorporated in the Purchased Assets (provided, however, that Closing Net Working Capital
shall exclude any deferred tax assets, deferred tax liabilities, and any VAT recoverable that is attributable to VAT for which Purchaser is required to indemnify or pay Sellers under Section 9.1(f), Section 9.8(a) or Section 9.8(c) of
this Agreement), minus (b) the sum of all Accounts Payable, Intercompany Payables (excluding Non-Trade Intercompany Payables), other current accrued liabilities of the Acquired Companies and of the Asset Selling Affiliates with respect to the
Transferred Employees (including all Liabilities in respect of accrued PTO (paid time off) or vacation or holiday pay for Transferred Employees to the extent not paid by the Seller or its applicable Affiliate to such employee prior to the Closing),
and deferred revenue. All elements of Closing Net Working Capital shall be calculated as of the opening of business on the Effective Date in the applicable jurisdiction and reflect the exclusion of the Excluded Assets, Excluded

  
 - 3 -

 
Liabilities, Retained Assets and Retained Liabilities. Notwithstanding Section 11.10, to determine the Closing Net Working Capital, all line items expressed in any currency other than U.S.
dollars will be converted into U.S. dollars using the closing rate quoted by Bloomberg as of 5 p.m. Eastern time on the last Business Day prior to Effective Date. Notwithstanding the preceding, for the avoidance of doubt, the Final Closing Net
Working Capital shall be calculated on a basis consistent with the Reference Calculation.” 
 and a new definition is
hereby added to Section 1.1 of the Agreement, as follows: 
 “Additional Gort Inventory” means all
inventory of MM Products (as defined in the Transition Services Agreement) and CPET (as defined in the Transition Services Agreement) located at the Gort, Ireland facility of CareFusion Manufacturing Ireland 241 Limited. 

(b) The first sentence of Section 2.7(a) is hereby amended and restated in its entirety as follows: 

“No later than five (5) Business Days prior to the Closing Date, the Sellers shall deliver to the Purchaser a certificate
executed by the Vice President, Senior Vice President, President or Chief Executive Officer of each of the Sellers dated as of the date of delivery, certifying as to a good faith estimate of the following (the “Pre-Closing
Adjustment Notice”): (i) the Closing Net Working Capital, reflecting the exclusion of the Excluded Assets, Excluded Liabilities, Retained Assets and Retained Liabilities (the “Estimated Closing Net Working Capital”)
and the Estimated Closing Net Working Capital Adjustment, (ii) the Closing Indebtedness (the “Estimated Closing Indebtedness”).” 
 (c) Section 2.7 of the Agreement is hereby amended by adding the following paragraph (l): 
 “(l) The parties hereby acknowledge that (i) until the completion of the actions required to effect the Reorganization pursuant to Section 5.11 of the Agreement have taken place, various
Employees in the United States of America are employed by an Affiliate of Sellers (the “Existing Employer”), and not by CareFusion 209, Inc (an Acquired Company) (“CareFusion 209”); (ii) the Reorganization will
involve the transfer of such employees from the Existing Employer to CareFusion 209; (iii) the Existing Employer will have a Liability for U.S. payroll with respect to such Employees as of the Closing Date (the “U.S. Employee Payroll
Liability”), which is reflected in the books of CareFusion 209; and (iv) notwithstanding any other provision of this Agreement, given that the Existing Employer will be required to settle the U.S. Employee Payroll Liability via
payments to the various Employees and Tax authorities and other parties, as appropriate, and yet such amount would otherwise be included in the Closing Net Working Capital, the Closing Net Working Capital will be increased for the amount of the U.S.
Employee Payroll Liability, insofar as such liability is paid or settled by the Existing Employer and, for the sake of clarity and to avoid duplication, the amount of such payment or settlement has not been or is not taken into account in
calculating the Closing Net Working Capital as another component thereof (e.g., Intercompany Receivable), and reasonably satisfactory 

  
 - 4 -

 
evidence of such payment or settlement is provided from the Sellers to the Purchaser.” 
 Section 6. Final Allocation Statement. For purposes of Section 2.8(a) of the Agreement, the parties acknowledge and agree that the Final Allocation Statement shall be as set forth in
Exhibit III hereto. 
 Section 7. Closing Date. Section 2.9 of the Agreement is hereby deleted and
replaced with the following: 
 “The closing of the transactions contemplated by this Agreement (the
“Closing”) shall occur on the later of (i) July 2, 2012, and (ii) three Business Days after the date on which all of the conditions set forth in Article 6 have been satisfied or waived (other than those
conditions that by their nature can only be satisfied at the Closing). The date on which the Closing actually occurs is referred to in this Agreement as the “Closing Date” while the date on which the transactions contemplated by
this Agreement shall be deemed effective is referred to in this Agreement as the “Effective Date.” Subject to the Closing occurring, the Effective Date shall be July 1, 2012. For all purposes under this Agreement and each of
the Ancillary Agreements, all matters at Closing will be considered to become effective simultaneously, no delivery of any document will be deemed complete until all transactions and deliveries of documents are completed, and the Effective Date of
the transactions contemplated by this Agreement will be deemed to have occurred at 12:01 a.m. in each jurisdiction applicable to the Business on the Effective Date irrespective of the actual occurrence of (but subject to) the Closing.”

 Section 8. CareFusion Austria 322 GmbH. The parties hereby acknowledge and agree that: (a) an existing
employee of CareFusion Austria 322 GmbH, who performs services primarily on behalf of the Business, has tendered his resignation, with effect from July 31, 2012; (b) the Purchaser will have no obligation to offer employment to, or employ,
such individual pursuant to Section 10.3 of the Agreement with effect from Closing; and (c) in consideration for not having to employ such individual from Closing, the Purchaser will promptly reimburse the Sellers (on behalf of CareFusion
Austria 322 GmbH) the cost of such individual’s salary and out-of-pocket benefit costs from the Closing Date through July 31, 2012. 
 Section 9. CareFusion 209 Employees. The parties hereby acknowledge and agree that: (a) the employment of two employees of CareFusion 209, who perform services in Dublin, Ohio primarily
on behalf of the Business, has been terminated, with effect June 30, 2012, (b) the Purchaser will have no obligation to offer employment to, or employ, such individuals pursuant to Section 10.3 of the Agreement with effect from
Closing; and (c) the Purchaser will be responsible for, indemnify and hold harmless, or procure that the appropriate Designated Affiliate will be responsible for, indemnify and hold harmless, the Sellers and their Affiliates from any
Liabilities and Losses which arise from or are connected with the dismissal of such employees (including all or any severance payments, compensation, damages or penalties (whether awarded by a court or agreed by the Selling Affiliate, or CareFusion
209 prior to the Closing) made to such employee as a result of or in connection with such dismissal). 
 Section 10.
Systems Software Confidentiality. Section 5.18 of the Agreement is hereby amended by adding the following paragraph (b): 

  
 - 5 -

 “(b) For a period of two years after the Closing, the Purchaser will, and will cause
its Affiliates (including the Acquired Companies) to, use commercially reasonable efforts to hold in confidence (in a manner substantially consistent with how the Purchaser protects its own similarly situated confidential information), unless
compelled to disclose by judicial or administrative process or by other requirements of Law, all non-public information or data contained within, or transferred in connection with the assignment, transfer or cloning of, the Required Systems
Software, to the extent such information or data relates to the business retained by the Sellers or their Affiliates and is not used or held for use in the Business (the “Non-Business Information”), except to the extent that such
Non-Business Information (i) must be disclosed in connection with the obligations of the Purchaser or the Acquired Companies pursuant to this Agreement and the Ancillary Agreements, (ii) can be shown to have been in the public domain
through no fault of the Purchaser, the Acquired Companies or its or their directors, officers, employees and advisors or (iii) was lawfully acquired by the Purchaser from a source that is not restricted by Law, contract or fiduciary duty from
disclosing such information. Notwithstanding the foregoing, in no event will this Section 5.18(b) limit or otherwise restrict the right of the Purchaser or the Acquired Companies and their respective Affiliates to disclose such Non-Business
Information to any Governmental Authority or arbitrator to the extent reasonably required in connection with any Proceeding relating to the enforcement of this Agreement or any Ancillary Agreement.” 

Section 11. Shared Tooling. A new Section 5.23 is hereby added to the Agreement, as follows: 

“Shared Tooling. Section 5.23 of the Seller Disclosure Schedule sets forth certain assets (the “Shared
Tooling”) currently used by the Sellers and its Affiliates in each of (i) the Business and (ii) the respiratory sleep diagnostic and service business of the Sellers and its Affiliates (other than the Acquired
Companies). To the extent any such Shared Tooling is a Purchased Asset or held by the Acquired Companies, the Purchaser hereby agrees that after the Closing Date, the Sellers, their Affiliates, employees, agents and representatives shall
continue to have access to and use of such Shared Tooling consistent with such Persons’ access to and use of such Shared Tooling prior to the Closing Date. To the extent any such Shared Tooling is an Excluded Asset or does not otherwise
transfer to the Purchaser at Closing, each of the Sellers hereby agree that after the Closing Date, the Purchaser, its Affiliates (including the Acquired Companies), employees, agents and representatives shall continue to have access to and use of
such Shared Tooling consistent with such Persons’ use of such Shared Tooling prior to the Closing Date. Each of the parties agrees that it shall not divest, relocate or otherwise take any action inconsistent with the terms
of this Section 5.23 with respect to any such Shared Tooling without the prior written consent of the other parties hereto provided that such consent shall not be unreasonably withheld or delayed and, in relation to any such
relocation (a) would not materially affect such other parties’ rights hereunder with respect to such Shared Tooling, (b) would be to a location no more than 30 miles from its previous location and (c) would not impose more than
de minimis additional costs on such other parties to continue to access and use such Shared Tooling. Each of the Purchaser (on the one hand) and the Sellers (on the other hand) agree to bear fifty percent (50%) of any maintenance,
replacement or insurance costs with respect to any Shared Tooling (whether a Purchased Asset or Excluded Asset). The parties agree to retain any documentation (including design specifications) with respect to the Shared Tooling and afford the
other parties and their representatives, during normal business hours of the requested party and at the requesting party’s expense, reasonable access to such documentation in such requested party’s possession and the right to make copies
and extracts therefrom.

  
 - 6 -

 
Notwithstanding the foregoing, the Purchaser (with respect to any Shared Tooling that is an Excluded Asset or does not otherwise transfer to the Purchaser at Closing) or the Sellers (with respect
to any Shared Tooling that is a Purchased Asset or held by the Acquired Companies) may provide notice to the other party hereto terminating its rights (including access and use thereof after the date of such notice) and obligations (including its
portion of any maintenance or replacement costs after the date of such notice) under this Section 5.23 with respect to any such Shared Tooling owned by the other party identified in such notice.” 

Section 12. Import Bond. A new Section 5.24 is hereby added to the Agreement, as follows: 

“(a) As reasonably required, the Purchaser will use its reasonable best efforts to have CareFusion 209, and specifically its IRS EIN,
added as importer to the continuous import bond described in Section 5.24 of the Seller Disclosure Schedule (“Import Bond”), and to cause the Sellers and their Affiliates (as applicable) to be fully released and discharged
therefrom, as soon as reasonably practicable after the Closing Date and, in any event, within fifteen (15) Business Days after the Closing Date. 
 (b) Until the Sellers and their Affiliates (as applicable) are fully released and discharged from any obligations under or with respect to the Import Bond, if any, the Purchaser will indemnify and hold
the Sellers and their Affiliates harmless from and against, and pay and reimburse the Sellers and all Affiliates of Sellers for, any and all Losses that the Sellers or any of their Affiliates suffer as a result of being required to make any payment
under the Import Bond after the Closing Date or as a result of the failure of the Purchaser or any of its Affiliates to meet any obligations under or with respect to the Import Bond.” 

Section 13. Retained Gort Employee. Section 10.5(b) of the Agreement is hereby amended by adding the following sentence
at the end of such section: 
 “Notwithstanding the above (i) the Sellers may or may cause an Affiliate to offer
employment, from the Closing Date to the date that is 30 days after the Termination Date (as defined in Schedule B to the Transition Services Agreement), to any of those employees listed in Section 10.5(b) of the Seller Disclosure Schedule
hereto (such employees offered employment by the Sellers or their Affiliates, the “Retained Gort Employees”) unless the employment by a Seller or an Affiliate of a Seller of such employee would compromise the ability of the
Purchaser, in its reasonable business discretion, to provide the services required pursuant to Schedule B of the Transition Services Agreement, (ii) if such Retained Gort Employees accept such offer of employment by the Sellers or any of their
Affiliates, or any employee identified on Section 10.5(b) of the Seller Disclosure Schedule voluntarily terminates his or her employment prior to the Termination Date (each such person, a “Resigning Gort Employee”), then the
employees identified on Section 10.5(b) of the Seller Disclosure Schedule will exclude, and the indemnification provided by Sellers under this Section 10.5(b) (other than with respect to the grant under the IDA Agreement) will not apply
with respect to, each such Retained Gort Employee and Resigning Gort Employee. The indemnity provided for in this Section 10.5(b) shall (A) only apply provided that in the case of dismissal of any employees listed in Section 10.5(b)
of the Seller Disclosure Schedule by the Purchaser or any of its Affiliates (including the Acquired Companies from Closing), such dismissal process is carried out (1) with the prior written approval of the Sellers (such approval not to be
unreasonably withheld or delayed, but taking into account any services still to be provided by Purchaser under the Transition Services 

  
 - 7 -

 
Agreement) and (2) within 30 days after the Termination Date (as defined in Schedule B to the Transition Services Agreement), and (B) not apply, with respect to repayment of any grant
provided for under the IDA Agreement, to the extent Purchaser (or the applicable Acquired Company) repays, but then becomes again entitled to, any such grant (including because Purchaser (or the applicable Acquired Company) dismisses such employees
listed in Section 10.5(b) of the Seller Disclosure Schedule and subsequently hires different qualifying employees under the IDA Agreement).” 
 Section 14. China Employees. The parties acknowledge and agree that, if the Purchaser fails to (or fails to cause its Designated Affiliates to) offer employment to the Employees in China (in
accordance with the second sentence of Section 10.3 of the Agreement) prior to the Closing, then any dismissal of such Employees by the Sellers (or their Affiliates) will be subject to indemnification by the Purchaser pursuant to
Section 10.6(b)(ii) of the Agreement. 
 Section 15. Exceptions to Non-Solicitation Obligations. The parties
hereby acknowledge and agree that neither the Sellers, CareFusion Corporation nor any of its Subsidiaries will be in breach of Section 5.14 of the Agreement as a result of any solicitation or employment of any employees listed in
Section 10.5(b) of the Seller Disclosure Schedule or that certain Employee listed in Section 5.14 of the Seller Disclosure Schedule. 
 Section 16. Post-Closing Cooperation. Section 5.16(a) of the Agreement is hereby amended and restated in its entirety as follows: 

“(a) Subject to Article 9, for the longer of the period required by applicable Law or six (6) years following the Closing Date,
each of the Sellers (on the one hand) and the Purchaser (on the other) will (i) retain books and records relating to (A) the Business or the Acquired Companies, and (B) with respect to the Purchaser, any business of the Sellers (or
their Affiliates), which are included in the Purchased Assets or otherwise held by the Acquired Companies, in each case to the extent in the respective party’s possession with respect to periods prior to the Closing (together, the
“Applicable Books and Records”), and (ii) afford the other parties and their representatives, during normal business hours of the requested party and at the requesting party’s expense, reasonable access to the Applicable
Books and Records in their possession with respect to periods prior to the Closing and the right to make copies and extracts therefrom, to the extent that such access may be reasonably required by the requesting party.” 

Section 17. Amendments to the Seller Disclosure Schedules. The Seller Disclosure Schedule is hereby supplemented, as set
forth in Exhibit IV hereto. Such supplements to the Seller Disclosure Schedule are provided for informational purposes (subject to the terms of Section 11.7 of the Agreement), but no such supplement will be deemed to cure the
representations and warranties to which such matters relate with respect to satisfaction of the conditions set forth in Section 6.1(a) or otherwise affect any other term or condition contained in the Agreement. 

Section 18. The Transition Services Agreement, a form of which was attached to the Agreement as Exhibit A, is hereby replaced
with the form of Transition Services Agreement attached hereto as Exhibit V. 
 Section 19. Reference to the
Agreement. On and after the date hereof, each reference in the Agreement to “this Agreement”, “hereof”, “herein”, “herewith”, “hereunder” and words of similar import shall, unless otherwise
stated, be construed to refer to the Agreement as 

  
 - 8 -

 
amended by this Amendment. No reference to this Amendment need be made in any instrument or document at any time referring to the Agreement, a reference to the Agreement in any such instrument or
document to be deemed to be a reference to the Agreement as amended by this Amendment. 
 Section 20.
Interpretation. The Agreement shall not be amended or otherwise modified by this Amendment except as expressly set forth in this Amendment. The terms, covenants and provisions of the Agreement that have not been amended hereby shall remain in
full force and effect in accordance with their respective terms. The terms, covenants and provisions of the Agreement amended hereby shall remain in full force and effect as amended hereby. In the event of any inconsistency or contradiction between
the terms of this Amendment and the Agreement, the terms of this Amendment shall prevail and control. 
 Section 21.
Governing Law. The internal laws of the State of Delaware (without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of laws of any
other jurisdiction) govern all matters arising out of or relating to this Amendment and its Exhibits, including its validity, interpretation, construction, performance and enforcement and any disputes or controversies arising therefrom or related
thereto. 
 Section 22. Jurisdiction and Service of Process. Any action or proceeding arising out of or relating to
this Amendment or the transactions contemplated by this Amendment must be brought in the courts of the State of Delaware, County of Wilmington, or, if it has or can acquire jurisdiction, in the United States District Court for the District of
Delaware. Each of the parties knowingly, voluntarily and irrevocably submits to the exclusive jurisdiction of each such court in any such action or proceeding and waives any objection it may now or hereafter have to venue or to convenience of forum.
Each party to this Amendment may make service on the other party by sending or delivering a copy of the process to the party to be served at the address and in the manner provided for the giving of notices in Section 11.1 of the Agreement.
Nothing in this Section 22, however, affects the right of a party to serve legal process in any other manner permitted by law. 
 Section 23. Counterparts. The parties may execute this Amendment in multiple counterparts, each of which constitutes an original as against the party that signed it, and all of which together
constitute one agreement. This Amendment is effective upon delivery of one executed counterpart from each party to the other party. The signatures of all parties need not appear on the same counterpart. The delivery of signed counterparts by
facsimile or email transmission that includes a copy of the sending party’s signature(s) is as effective as signing and delivering the counterpart in person. 

  
 - 9 -

 The parties have executed and delivered this Amendment as of the date indicated in the
initial sentence of this Amendment. 
  

			
	CAREFUSION 303, INC.
		
	By:	 	  

		 	 Name:

Title:

	
	CAREFUSION 2200, INC.
		
	By:	 	  

		 	 Name:

Title:

	
	NATUS MEDICAL INCORPORATED
		
	By:	 	  

		 	 Name:

Title:

  
 - 10 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]